Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax(®)

BACKGROUND: Melanoma tumors are known to express antigens that usually induce weak immune responses of short duration. Expression of both tumor-associated antigens p53 and TRP2 by melanoma cells raises the possibility of simultaneously targeting more than one antigen in a therapeutic vaccine. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Marc, Pohajdak, Bill, Kast, W Martin, Fuentes-Ortega, Antar, Korets-Smith, Ella, Weir, Genevieve M, Brown, Robert G, Daftarian, Pirouz
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867806/
https://www.ncbi.nlm.nih.gov/pubmed/17451606
http://dx.doi.org/10.1186/1479-5876-5-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867806/
https://www.ncbi.nlm.nih.gov/pubmed/17451606
http://dx.doi.org/10.1186/1479-5876-5-20

Ejemplares similares